Hyperbranched Maltodextrin Composition for Enzyme-Resistant Glycemic Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies lack low molecular weight, highly branched polysaccharides that effectively act as barrier agents to digestive enzymes, reducing carbohydrate digestion and blood glucose rise postprandially, particularly for diabetic management.
Innovation Solution
Development of hyperbranched maltodextrins with specific characteristics: DE 8-15, Mw 1700-3000 daltons, 30-45% 1→6 glycosidic linkages, and 75-100% soluble indigestible fiber content, achieved through a process involving dehydration, high-temperature treatment, and enzymatic modification to enhance enzymatic resistance and hypoglycemic properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional low molecular weight branched polysaccharides are used, then they can be produced with moderate branching, but they fail to effectively act as barrier agents to digestive enzymes and do not significantly reduce carbohydrate digestion
Solution Approach 1:
The patent changes critical parameters of the polysaccharide structure: increasing the branching degree to hyperbranched configuration, optimizing molecular weight to 1700-3000 daltons, and controlling dextrose equivalent to 8-15. These parameter modifications transform the polysaccharide into an effective barrier agent that reduces α-amylase hydrolysis by 80-90% in vitro and intestinal digestive activity by 30-45% in situ.
Solution Approach 2:
The invention creates a composite structure within the polysaccharide molecule itself, with a core-globular architecture containing multiple 1→6 glucosidic bonds (30-45% content) arranged in a hyperbranched configuration. This internal composite structure provides both the barrier function and the indigestible fiber characteristics needed for glycemic control.
2Ease of operation
If standard maltodextrins are used, then they are completely soluble in water and have low reducing power, but they cause significant postprandial blood sugar increase and insulin secretion
Solution Approach 1:
The patent applies local quality modification by introducing specific 1→6 glucosidic bonds at strategic positions within the polysaccharide structure. These localized branching points create steric hindrance that blocks α-amylase enzyme access to the linear 1→4 glucosidic bonds, thereby protecting against hydrolysis while maintaining overall solubility.
Solution Approach 2:
The hyperbranched maltodextrin acts as an intermediary substance that interferes with the action of α-amylase on standard maltodextrins. Through its hyperbranched structure with high 1→6 bond content, it forms a protective barrier that reduces enzyme-substrate interaction, thereby mediating the reduction of blood sugar spikes without compromising solubility.
3Object-affected harmful factors
If soluble fibers are used to slow down gastric emptying and decrease carbohydrate absorption rate, then postprandial glycaemia is reduced, but the mechanism is not fully understood and application is limited
Solution Approach 1:
The hyperbranched maltodextrin performs multiple functions simultaneously: it acts as a barrier to α-amylase, provides soluble indigestible fiber (75-100% content), slows gastric emptying, and reduces carbohydrate absorption. This self-service capability eliminates the need for multiple separate interventions, simplifying the overall mechanism while effectively reducing postprandial glycaemia.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Hyperbranched maltodextrins reduce α-amylase hydrolysis of standard maltodextrins by 80-90% in vitro and intestinal digestion by 30-45% in situ, effectively managing blood glucose levels and insulin secretion.
Implementation Method 1
reduce by 80 to 90% the hydrolysis by α-amylase of said standard maltodextrins
Implementation Method 2
lengthening of the gastric emptying time by increasing the viscosity of the food bolus
Implementation Method 3
soluble fibres, such as pectin and inulin, which are not digestible by human intestinal enzymes, are fermented by the intestinal bacterial flora. This fermentation releases short-chain fatty acids in the colon
Implementation Method 4
increase in the viscous layer that lines the small intestine, also slowing down the absorption time of nutrients
Data Source
AI summary
The invention relates to hyper-branched maltodextrins having a dextrose equivalent (DE) between at least 8 and at most 15 and a molecular weight or Mw between at least 1,700 and at most 3,000 daltons, characterized in that same have: a 1,6 glucoside bond content between at least 30 and at most 45%; a soluble indigestible fiber content, which is determined according to the AOAC No. 2001-03 method, between at least 75 and at most 100%; and a hypoglycemic capacity expressed according to a test A, which: - in vitro, results in an 80 to 90% reduction of the alpha-amylase hydrolysis of standard maltodextrins, and - in situ, by a 30 to 45% reduction in the intestinal digestive activity of standard maltodextrins.